Sponsor:
Mayo Clinic
Code:
NCT06315595
Conditions
Prostate Neoplasm
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Non-Interventional Study
Brief summary:
Conditions
Prostate Neoplasm
Study ID
NCT06315595
Start date
Sep 30, 2015
Status verified date
Apr, 2026
Completion date
Sep 30, 2030
Anticipated
Primary completion date
Sep 30, 2030
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
1000 participants
Anticipated
Arms
Observational
Interventions
Non-Interventional Study
Primary outcome measure
Central contacts
Locations
Mayo Clinic in Rochester
Recruiting
Rochester, Minnesota, United States, 55905
Contacts
Clinical Trials Referral Office
855-776-0015Principal Investigator:
Stephen J. Riederer, PhD
Sponsor
Mayo Clinic
Last update posted
Apr 17, 2026
Last verified
Apr, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2026-04-17.